通过氨酸-基酸悬挂修改工程一个对葡萄糖敏感的葡萄糖原药
Emily L DeWolf1, Weike Chen1, Bernice Webber2
1Department of Chemical & Biomolecular Engineering University of Notre Dame Notre Dame Indiana USA.
Small science
|March 11, 2026
概括
这项研究引入了一种新的葡萄糖反应性葡萄糖原药,用于降血糖保护. 创新的设计根据葡萄糖水平自我调节治疗释放,防止危险的低血糖事件.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 材料科学 材料科学 材料科学
背景情况:
- 可激活的前药可以在空间和时间上精确控制药物输送.
- 开发有效的策略来管理低血糖症,糖尿病治疗的常见并发症,仍然至关重要.
研究的目的:
- 设计和评估一种单分子,对葡萄糖反应的葡萄糖原药,用于降血糖保护.
- 为自我调节的疗法建立一个模块化设计.
主要方法:
- 达西格卢卡贡与交替的阿尔金因和酸 (PBA) 单位的合成吊的结合.
- 通过依赖葡萄糖的PBA-diol复合,调节净电荷和可溶性.
- 在胰岛素过量剂量的链毒素诱导的糖尿病小鼠模型中的体内测试.
主要成果:
- 主导前药物设计表现出最佳的葡萄糖响应溶解度和电荷调制.
- 前药在高葡萄糖时形成聚合物,并且随着葡萄糖水平的下降而溶解.
- 这种前药在小鼠中显示出显著的预防性保护,防止胰岛素诱导的低血糖症,消除了死亡率.
结论:
- 这项工作提出了对代谢物反应性葡萄糖原药的概念证明,作为按需治疗仓库.
- 这项研究建立了基于电荷调节的动态,自我调节的疗法的模块化设计范式.
相关概念视频
Glucagon-like Receptor Agonists
1.1K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.1K
Insulin: Biosynthesis, Chemistry, and Preparation
1.7K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.7K
Hypoglycemia and Glucagon
1.1K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.1K
Prodrugs
4.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
4.6K
GPCRs Regulate Adenylyl Cylase Activity
8.0K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.0K
Preparation of 1° Amines: Gabriel Synthesis
4.9K
Direct alkylation is not a suitable method for synthesizing amines because it produces polyalkylated products. Gabriel synthesis is the most preferred method to exclusively make primary amines. The method uses phthalimide, which contains a protected form of nitrogen that participates in alkylation only once to predominantly give primary amines.
Strong bases like NaOH or KOH deprotonate the phthalimide to form the corresponding anion, which acts as a nucleophile. Further, the anion attacks an...
Strong bases like NaOH or KOH deprotonate the phthalimide to form the corresponding anion, which acts as a nucleophile. Further, the anion attacks an...
4.9K


